Metformin Activates Wnt/β-catenin for the Treatment of Diabetic Osteoporosis

Overview

Journal BMC Endocr Disord

Publisher Biomed Central

Specialty Endocrinology

Date 2022 Jul 22

PMID 35869471

Authors

Xiaopeng Huang

Siyun Li

Wenjie Lu

Longjiang Xiong

Affiliations

Soon will be listed here.

Abstract

Background: With the deepening of social aging, the incidence rate of osteoporosis and diabetes continues to rise. More and more clinical studies show that diabetes is highly correlated with osteoporosis. Diabetes osteoporosis is considered as a metabolic bone disease of diabetes patients. This study aims to explore the role and mechanism of metformin (Met) in diabetic osteoporosis.

Methods: Mouse MC3T3-E1 cells were treated with Met (0.5 mM) and exposed to high glucose (HG, 35 mM). The cells were cultured in an osteogenic medium for osteogenic differentiation, and the cell proliferation ability was determined using Cell Counting Kit-8; Alkaline phosphatase (ALP) activity detection and alizarin red staining were utilized to evaluate the effect of Met on MC3T3-E1 osteogenic differentiation. Western blot was used to detect the expressions of osteogenesis-related proteins (Runx2 and OCN) as well as Wnt/β-catenin signaling pathway-related proteins in MC3T3-E1 cells.

Results: HG inhibited proliferation and calcification of MC3T3-E1 cells, down-regulated ALP activity, and the expression of Runx2 and OCN in MC3T3-E1 cells. Meanwhile, the activity of the Wnt/β-catenin signaling pathway was inhibited. Met treatment was found to significantly stimulate the proliferation and calcification of MC3T3-E1 cells under HG conditions, as well as increase the ALP activity and the protein expression level of Runx2 and OCN in the cells. As a result, osteogenic differentiation was promoted and osteoporosis was alleviated. Apart from this, Met also increased the protein expression level of Wnt1, β-catenin, and C-myc to activate the Wnt/β-catenin signaling pathway.

Conclusion: Met can stimulate the proliferation and osteogenic differentiation of MC3T3-E1 cells under HG conditions. Met may also treat diabetic osteoporosis through Wnt/β-catenin activation.

Citing Articles

Effects of ADRM1 on osteoblast differentiation and mineralization in osteoporosis.

Zhuang H, Lin Y, Lin C, Zheng M, Yao X, Xu Y Am J Transl Res. 2025; 17(1):416-428.

PMID: 39959199 PMC: 11826214. DOI: 10.62347/XSOV4523.

Osteoporosis in Adrenal Insufficiency: Could Metformin be Protective?.

Turki Jalil A, Abdulhadi M, Al-Ameer L, Abd-Alzahraa Z, Merza M, Zabibah R Indian J Clin Biochem. 2025; 40(1):4-11.

PMID: 39835225 PMC: 11741967. DOI: 10.1007/s12291-023-01153-0.

The ameliorative potential of metformin against aluminum-induced neurotoxicity: Insights from in vitro studies.

Sanajou S, Yirun A, Demirel G, Erkekoglu P, Sahin G, Baydar T J Appl Toxicol. 2024; 45(2):245-255.

PMID: 39275926 PMC: 11738538. DOI: 10.1002/jat.4695.

Chromium Picolinate Regulates Bone Metabolism and Prevents Bone Loss in Diabetic Rats.

Zheng H, Yan W, Shao M, Qi S Molecules. 2024; 29(5).

PMID: 38474436 PMC: 10935143. DOI: 10.3390/molecules29050924.

Effect of metformin on Wnt5a in individuals new-onset type 2 diabetes with different body mass indexes: The evidences from the real word research.

Liu X, Qiu Q, Yu T, Wang L, Shi L, Wang B J Diabetes Metab Disord. 2023; 22(2):1561-1570.

PMID: 37975126 PMC: 10638164. DOI: 10.1007/s40200-023-01286-2.

References

Moerman E, Teng K, Lipschitz D, Lecka-Czernik B . Aging activates adipogenic and suppresses osteogenic programs in mesenchymal marrow stroma/stem cells: the role of PPAR-gamma2 transcription factor and TGF-beta/BMP signaling pathways. Aging Cell. 2004; 3(6):379-89. PMC: 1850101. DOI: 10.1111/j.1474-9728.2004.00127.x. View

Batandier C, Guigas B, Detaille D, El-Mir M, Fontaine E, Rigoulet M . The ROS production induced by a reverse-electron flux at respiratory-chain complex 1 is hampered by metformin. J Bioenerg Biomembr. 2006; 38(1):33-42. DOI: 10.1007/s10863-006-9003-8. View

Tolosa M, Chuguransky S, Sedlinsky C, Schurman L, McCarthy A, Molinuevo M . Insulin-deficient diabetes-induced bone microarchitecture alterations are associated with a decrease in the osteogenic potential of bone marrow progenitor cells: preventive effects of metformin. Diabetes Res Clin Pract. 2013; 101(2):177-86. DOI: 10.1016/j.diabres.2013.05.016. View

Napoli N, Strotmeyer E, Ensrud K, Sellmeyer D, Bauer D, Hoffman A . Fracture risk in diabetic elderly men: the MrOS study. Diabetologia. 2014; 57(10):2057-65. PMC: 4344350. DOI: 10.1007/s00125-014-3289-6. View

Wang P, Ma T, Guo D, Hu K, Shu Y, Xu H . Metformin induces osteoblastic differentiation of human induced pluripotent stem cell-derived mesenchymal stem cells. J Tissue Eng Regen Med. 2017; 12(2):437-446. PMC: 5696118. DOI: 10.1002/term.2470. View

He X, Semenov M, Tamai K, Zeng X . LDL receptor-related proteins 5 and 6 in Wnt/beta-catenin signaling: arrows point the way. Development. 2004; 131(8):1663-77. DOI: 10.1242/dev.01117. View

Vestergaard P, Rejnmark L, Mosekilde L . Are antiresorptive drugs effective against fractures in patients with diabetes?. Calcif Tissue Int. 2010; 88(3):209-14. DOI: 10.1007/s00223-010-9450-4. View

Lv Z, Guo Y . Metformin and Its Benefits for Various Diseases. Front Endocrinol (Lausanne). 2020; 11:191. PMC: 7212476. DOI: 10.3389/fendo.2020.00191. View

Wang Y, Qu X, Yang Y, Han X, Wang L, Qiao H . AMPK promotes osteogenesis and inhibits adipogenesis through AMPK-Gfi1-OPN axis. Cell Signal. 2016; 28(9):1270-1282. DOI: 10.1016/j.cellsig.2016.06.004. View

10.

Visweswaran M, Pohl S, Arfuso F, Newsholme P, Dilley R, Pervaiz S . Multi-lineage differentiation of mesenchymal stem cells - To Wnt, or not Wnt. Int J Biochem Cell Biol. 2015; 68:139-47. DOI: 10.1016/j.biocel.2015.09.008. View

11.

Kanazawa I, Yamaguchi T, Yamamoto M, Yamauchi M, Kurioka S, Yano S . Serum osteocalcin level is associated with glucose metabolism and atherosclerosis parameters in type 2 diabetes mellitus. J Clin Endocrinol Metab. 2008; 94(1):45-9. DOI: 10.1210/jc.2008-1455. View

12.

Yu W, Xie C, Chen F, Cheng P, Yang L, Pan X . LGR5 enhances the osteoblastic differentiation of MC3T3-E1 cells through the Wnt/β-catenin pathway. Exp Ther Med. 2021; 22(2):889. PMC: 8237272. DOI: 10.3892/etm.2021.10321. View

13.

Zhou R, Ma Y, Qiu S, Gong Z, Zhou X . Metformin promotes cell proliferation and osteogenesis under high glucose condition by regulating the ROS‑AKT‑mTOR axis. Mol Med Rep. 2020; 22(4):3387-3395. PMC: 7453594. DOI: 10.3892/mmr.2020.11391. View

14.

Kikuchi A, Yamamoto H, Kishida S . Multiplicity of the interactions of Wnt proteins and their receptors. Cell Signal. 2006; 19(4):659-71. DOI: 10.1016/j.cellsig.2006.11.001. View

15.

Chen S, Brooks R, Houskeeper J, Bremner S, Dunlop J, Viollet B . Metformin suppresses adipogenesis through both AMP-activated protein kinase (AMPK)-dependent and AMPK-independent mechanisms. Mol Cell Endocrinol. 2016; 440:57-68. PMC: 5228588. DOI: 10.1016/j.mce.2016.11.011. View

16.

Montagnani A, Gonnelli S, Alessandri M, Nuti R . Osteoporosis and risk of fracture in patients with diabetes: an update. Aging Clin Exp Res. 2011; 23(2):84-90. DOI: 10.1007/BF03351073. View

17.

Heilmeier U, Patsch J . Diabetes and Bone. Semin Musculoskelet Radiol. 2016; 20(3):300-304. DOI: 10.1055/s-0036-1592366. View

18.

Pahwa H, Khan M, Sharan K . Hyperglycemia impairs osteoblast cell migration and chemotaxis due to a decrease in mitochondrial biogenesis. Mol Cell Biochem. 2020; 469(1-2):109-118. DOI: 10.1007/s11010-020-03732-8. View

19.

Chen L, Huang X, Li X, Zhang T, Hao C, Zhao Z . Geniposide promotes the proliferation and differentiation of MC3T3-E1 and ATDC5 cells by regulation of microRNA-214. Int Immunopharmacol. 2020; 80:106121. DOI: 10.1016/j.intimp.2019.106121. View

20.

Zhang T, Wang F, Li K, Lv C, Gao K, Lv C . Therapeutic effect of metformin on inflammation and apoptosis after spinal cord injury in rats through the Wnt/β-catenin signaling pathway. Neurosci Lett. 2020; 739:135440. DOI: 10.1016/j.neulet.2020.135440. View